STAT

APRIL 18, 2024

In the chaotic first few months of the Covid-19 pandemic, stores faced shortages of all kinds — toilet paper, canned food, and especially, cleaning supplies. With everyone scrubbing their groceries, mail, even library books, good luck finding antibacterial wipes or disinfectant sprays back then. That’s because public health advice in early 2020 focused on sanitizing surfaces, not protecting against a virus that could be spread through the air.

364

364

PharmaVoice

APRIL 15, 2024

The biotech is developing a ‘gene-agnostic’ approach to expand the patient pool for gene therapies.

362

362

BioPharma Dive

APRIL 18, 2024

It’s “early innings” in the obesity drug race, said Metsera CEO Clive Meanwell, whose company has acquired a portfolio of medicines it aims to test in combination.

126

126

ID Stewardship

APRIL 14, 2024

In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., PharmD, BCPS, BCIDP, AAHIV-M Disclaimer : This text and table is intended for use as a study tool to assist people learning pharmacotherapy of recurrent Clostridioides difficile infections (rCDI).

Hospitals 129

Hospitals Communication 129

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 18, 2024

As two former secretaries of Health and Human Services, we are all too familiar with the struggle of finding narrow openings for bipartisanship. Despite our different approaches, we believe that addressing health care costs is a truly bipartisan issue. To be serious about creating access for people to the best possible care, that care must be affordable for patients and taxpayers.

363

363

PharmaVoice

APRIL 19, 2024

Where Amylyx ultimately failed in ALS, it could prevail in a rare disease. The doctor leading this research explains why.

300

300

BioPharma Dive

APRIL 18, 2024

The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.

121

121

STAT

APRIL 18, 2024

An ongoing investigation into data integrity at Dana-Farber Cancer Institute has resulted in a string of retractions, the latest of which is a 2006 Science paper co-authored by institute president and CEO Laurie Glimcher. The retraction notice, published in Science on Thursday, noted that the authors had become aware of discrepancies in key scientific images that led them to lose confidence in key figures in the study, although the study’s lead author opposed the retraction.

362

362

The Pharmacist

APRIL 17, 2024

The majority of pharmacists applying to receive ‘advanced’ level credentialing from the Royal Pharmaceutical Society (RPS) work in primary care, analysis has shown. The credentialing assessment is designed to assure that pharmacists have the entry-level capabilities to deliver advanced level care to patients. Since the ‘advanced’ credentialing assessment was introduced a year ago, 39 pharmacists […] The post Majority of advanced credentialing candidates work in primary care appeared first

118

118

pharmaphorum

APRIL 18, 2024

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.

120

120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

APRIL 18, 2024

Analysts had low expectations for Cerevel’s drug tavapadon, which was something of an afterthought in AbbVie’s proposed buyout of the biotech.

126

126

STAT

APRIL 17, 2024

A new analysis of health inequities in the United States shows that every state has deep racial and ethnic disparities in the performance of their health care systems. The report released Thursday by the Commonwealth Fund analyzed 25 indicators that track health outcomes, health care access, and quality of care provided for five racial and ethnic groups.

361

361

The Pharmacist

APRIL 17, 2024

A new video campaign has been launched to encourage patients to accept appointments with healthcare professionals other than a GP, including practice pharmacists and pharmacy technicians. The Institute of General Practice Management’s (IGPM’s) ‘Right Care, First Time’ campaign aims to reduce ‘the burden’ on GPs and explain the benefit of utilising the experience of the […] The post New campaign highlights role of pharmacy staff in general practice appeared first on The Pharmacist.

Pharmacy Technician 118

Pharmacy Technician 118

pharmaphorum

APRIL 15, 2024

Psychedelic treatments for conditions like PTSD using substances like MDMA are on the brink of approval, but there are still unanswered questions surrounding their effectiveness and potential risks. Learn more here.

120

120

BioPharma Dive

APRIL 15, 2024

Treatment appeared to result in functional and cognitive gains in people with the neurological disorder. Three participants experienced lower extremity weakness, however.

122

122

STAT

APRIL 18, 2024

For a company moving as quickly as possible to build artificial intelligence into everything — including health care — Microsoft spends a lot of time talking about how to regulate it. The tech giant has helped organize four separate coalitions to devise guidelines and technical standards for AI in health care. It supplies these groups — composed of health systems, government regulators, and other health businesses — with top executives to serve on steering committees,

Hospitals 360

Hospitals 360

The Pharmacist

APRIL 19, 2024

The General Pharmaceutical Council (GPhC) has reached out to the Department of Health and Social Care (DHSC) to begin work on the recommendations of a major review into gender identity services for children and young people. Speaking in a council meeting on Thursday, GPhC chief executive Duncan Rudkin, said the regulator recognised ‘a degree of […] The post GPhC working through implications of Cass Review for pharmacists appeared first on The Pharmacist.

114

114

pharmaphorum

APRIL 19, 2024

Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.

112

112

BioPharma Dive

APRIL 19, 2024

The new label for Alecensa makes it the first targeted treatment available after surgery for people with ALK-positive lung tumors, who are at high risk for brain metastases.

Labelling 114

Labelling 114

STAT

APRIL 17, 2024

Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market. The results also pave the way for Zepbound to potentially become the first approved treatment for obstructive sleep apnea, or OSA, a common disorder characterized by breathing interruptions during sleep.

363

363

Pharmaceutical Technology

APRIL 18, 2024

Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.

129

129

pharmaphorum

APRIL 17, 2024

Learn about the importance of reshoring the UK pharmaceutical supply chain for future resilience. Discover how this strategic move can enhance local production and secure the availability of critical medications.

117

117

The Pharmacist

APRIL 16, 2024

Almost one in five adults and one in ten children receive a second course of antibiotics for the same respiratory tract infection, researchers have found. Analysis of GP records of more than 900,000 cases of respiratory tract infection across 530 practices in England also found that in half the cases of repeat antibiotic prescribing, the […] The post Significant proportion of RTIs given more than one antibiotic course appeared first on The Pharmacist.

116

116

STAT

APRIL 17, 2024

The fight against malaria is a test of human intelligence against mosquitoes — and so far, our minuscule winged enemy is winning. But new results shared this week show substantial improvements in one of the most important tools we have to prevent the life-threatening disease: bed nets. Results shared this week by the New Nets Project, an initiative funded by Unitaid and the Global Fund, highlighted a pair of second-generation bed nets tested in endemic areas between 2019 and 2022.

363

363

Pharmaceutical Commerce

APRIL 19, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Environtainer, suggests how to improve visibility and risk management for cold chain shipping.

105

105

pharmaphorum

APRIL 18, 2024

Embark on an omnichannel marketing odyssey by exploring the top trends reshaping the industry in 2024. Discover how chatbots, video content, and interactivity are transforming marketing strategies.

113

113

The Pharmacist

APRIL 16, 2024

Any level of passive smoking universally elevates the risk of atrial fibrillation, according to new research presented at the recent European Heart Rhythm Association congress. The researchers examined the association between secondhand smoke exposure and the long-term risk of incident atrial fibrillation, aiming to add to existing research that has established links between passive smoking and […] The post Passive smoking linked to increased risk of atrial fibrillation, new study finds ap

116

116

STAT

APRIL 19, 2024

Although U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year period, hospital doctors instead gave older, generic remedies to more than 40% of patients battling those stubborn pathogens, according to a new analysis. Moreover, 80% of the time these older antibiotics were already known to be highly toxic or ineffective, according to the analysis.

Hospitals 347

Hospitals 347

Pharma Times

APRIL 15, 2024

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis

145

145

pharmaphorum

APRIL 15, 2024

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.

117

117

The Pharmacist

APRIL 15, 2024

A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested. Investigators evaluating the glucagon-like peptide 1 receptor agonist (GLP-1 RA) lixisenatide reported less progression of motor disability over a 12-month period in patients taking the drug compared with placebo. But writing in the New England Journal of Medicine, they […] The post Diabetes drug shows potential in treating Parkinson’s disease appeared first on The Pharma

Diabetes 114

Diabetes 114

STAT

APRIL 17, 2024

When my son Conall took his life at age 17, it was devastating to me and our entire family. Conall was a caring, empathetic, and bright young man, but he had also struggled for many years with anxiety and depression. Like many kids his age, much of his life revolved around social media. While I understand that suicide is complex, with many different factors contributing to someone’s risk for it, I know that social media intensified and fueled Conall’s insecurities and ultimately ha

356

356

EMCrit Project

APRIL 15, 2024

A razor is a rule of thumb that is helpful, although it isn't always correct. In medicine we're familiar with Occam's razor (the rule of parsimony). The cutoff razor states: if a continuous variable is dichotomized using a cutoff, then values near the cutoff provide little information. A simple illustration of the cutoff razor is […] EMCrit Project by Josh Farkas.

110

110

pharmaphorum

APRIL 16, 2024

A smart sensor developed by Adherium has been cleared by the FDA for use with AstraZeneca's asthma inhaler Airsupra and Breztri for COPD.

130

130

The Pharmacist

APRIL 15, 2024

The NHS national booking system for spring Covid-19 vaccination bookings via pharmacies in England is now open. Those eligible to book appointments are able to do so for next week. They include adults aged 75 or over as of 30 June 2024, residents in care homes for older adults, and individuals who are immunosuppressed. The […] The post NHS opens national booking system for spring Covid-19 vaccinations appeared first on The Pharmacist.

Vaccines 111

Vaccines 111